Otonomy to Present at Cowen and Company Health Care Conference

Back to Jobs

SAN DIEGO , Feb. 29, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that David A. Weber , Ph.D., president and chief executive

Apply Now